Biotech stocks are in the eye of the storm as the world recovers from the global pandemic. Government institutions and professional traders are banking on biotech stocks to continually develop a ...

OpenAI’s board of directors has formally rejected an offer from a group of investors led by Elon Musk to buy the nonprofit for $97.4 billion. Scarlet Fu reports on “Bloomberg The Close.” ...